NCT06101472

Brief Summary

The goal of this observational study is to evaluate the rotational stability and clinical performance of the ASQELIO Toric lens in candidates for cataract surgery with ASQUELIO Toric intraocular lens (IOL) implantation. Information will be obtained from patients operated by routine clinical practice with toric monofocal ASQELIO IOL in at least one eye. After confirmation of inclusion, the preoperative examination will be performed, and after surgery an evaluation will be performed the following day, one week, one month and three months after surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
63

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2024

Shorter than P25 for all trials

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 20, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 26, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

February 1, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2024

Completed
Last Updated

January 31, 2024

Status Verified

October 1, 2023

Enrollment Period

6 months

First QC Date

September 20, 2023

Last Update Submit

January 30, 2024

Conditions

Keywords

Cataract

Outcome Measures

Primary Outcomes (2)

  • Rotational stability of the implant

    Evaluated at each visit by analysis of slit-lamp backlight images, following the method described by Wolffsohn and Buckhurst. By means of backlighting, the IOL markings indicating the axis in which the astigmatic power is located will be observed and by image analysis it will be determined and quantified whether the lens has been rotated.

    During 3 months after IOL implantation

  • Visual acuity

    Best corrected distance visual acuity in LogMAR units using the ETDRS chart

    During 3 months after IOL implantation

Secondary Outcomes (3)

  • Refraction

    During 3 months after IOL implantation

  • Adverse events

    During 3 months after IOL implantation

  • Satisfaction and quality of vision questionnaire

    During 3 months after IOL implantation

Study Arms (1)

Pseudophakic subjects implanted with the ASQELIO toric IOL

Adult subjects undergoing cataract surgery by routine clinical practice with ASQELIO Toric Biaspheric Monofocal Lens in at least one eye.

Device: ASQELIO Toric Biaspheric Monofocal Lens

Interventions

Intraocular lens implantation in cataract surgery

Pseudophakic subjects implanted with the ASQELIO toric IOL

Eligibility Criteria

Age22 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult subjects who are candidates for cataract surgery and implantation of toric monofocal ASQELIO IOL in at least one of their eyes.

You may qualify if:

  • Subjects 22 years of age or older undergoing cataract surgery in at least 1 eye and implanted with LIO ASQELIO.
  • Subjects for whom postoperative emmetropia was planned (±0.5 D spherical equivalent)

You may not qualify if:

  • Preoperative corneal astigmatism less than 0.75D
  • Patients who do not provide informed consent
  • Patients who do not understand the study procedure.
  • Previous corneal surgery or trauma.
  • Irregular cornea (e.g. keratoconus).
  • Microphthalmos.
  • Severe corneal dystrophy.
  • Pregnant or breastfeeding'.
  • Rubella
  • Mature/dense cataract making eye bottom preoperative examination difficult.
  • Previous retinal detachment.
  • Concurrent participation in other research with drugs or clinical devices.
  • Expect to require another eye surgery during the study period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Oftalvist Alicante

Alicante, 03013, Spain

RECRUITING

OftalVist Madrid

Madrid, 28006, Spain

RECRUITING

OftalVist Valencia

Valencia, 46004, Spain

RECRUITING

MeSH Terms

Conditions

Cataract

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Study Officials

  • Pedro Tañá, Dr

    Oftalmología Vistahermosa SL

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 20, 2023

First Posted

October 26, 2023

Study Start

February 1, 2024

Primary Completion

August 1, 2024

Study Completion

October 1, 2024

Last Updated

January 31, 2024

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations